Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sabra Health Care REIT, Inc.SBRA · Entity 886 | Director | November 30, 2021 | December 02, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sabra Health Care REIT, Inc.
Report date November 30, 2021 · Filed December 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 218,820 |
Reported balance
After 2021-11-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-11-30 · Grant · Acquired 789 · Balance 218,820 F1: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2: Includes 3,916 unvested stock units and 30,968 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
F2: Includes 3,916 unvested stock units and 30,968 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Care Capital Properties, Inc.
Report date August 17, 2017 · Filed August 18, 2017
Section 16 reporting ended · disclosed 2017-08-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2017-08-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-08-17 · Grant · Acquired 37,994 · Balance 282,862 F1: Pursuant to an Agreement and Plan of Merger, dated May 7, 2017 (the "Merger Agreement"), by and among Sabra Health Care REIT, Inc., a Maryland corporation ("Sabra"), Sabra Health Care Limited Partnership, a Delaware limited partnership, PR Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Sabra ("Merger Sub"), Care Capital Properties, Inc., a Delaware corporation (the "Issuer"), and Care Capital Properties, LP, a Delaware limited partnership, the outstanding performance-based restricted stock units held by the Reporting Person immediately prior to the effective time of the merger (the "Merger") of Issuer with and into Merger Sub vested in full and were converted into an aggregate 37,994 shares of Issuer common stock. Row 2 · 2017-08-17 · Disposition to issuer · Disposed 282,862 · Balance 0 F2: Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock was exchanged on August 17, 2017 for the right to receive 1.123 newly issued shares of Sabra's common stock (the "Merger Consideration"), subject to certain adjustments as set forth in the Merger Agreement. The closing price of shares of Sabra's common stock on August 16, 2017 was $21.72 per share. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.22 · Expires 2022-01-18 | Direct | 0 |
Reported balance
After 2017-08-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-08-17 · Disposition to issuer · Disposed 139,802 · Balance 0 F5: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F3: Fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.22 · Expires 2023-01-23 | Direct | 0 |
Reported balance
After 2017-08-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-08-17 · Disposition to issuer · Disposed 161,668 · Balance 0 F5: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F3: Fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.10 · Expires 2024-01-29 | Direct | 0 |
Reported balance
After 2017-08-17 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-08-17 · Disposition to issuer · Disposed 269,431 · Balance 0 F5: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F3: Fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.28 · Expires 2025-01-21 | Direct | 0 |
Reported balance
After 2017-08-17 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-08-17 · Disposition to issuer · Disposed 198,525 · Balance 0 F5: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F3: Fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.94 · Expires 2026-01-27 | Direct | 0 |
Reported balance
After 2017-08-17 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-08-17 · Disposition to issuer · Disposed 321,456 · Balance 0 F5: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F4: These options were granted on January 27, 2016 and were scheduled to vest in three equal annual installments beginning on the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to an Agreement and Plan of Merger, dated May 7, 2017 (the "Merger Agreement"), by and among Sabra Health Care REIT, Inc., a Maryland corporation ("Sabra"), Sabra Health Care Limited Partnership, a Delaware limited partnership, PR Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Sabra ("Merger Sub"), Care Capital Properties, Inc., a Delaware corporation (the "Issuer"), and Care Capital Properties, LP, a Delaware limited partnership, the outstanding performance-based restricted stock units held by the Reporting Person immediately prior to the effective time of the merger (the "Merger") of Issuer with and into Merger Sub vested in full and were converted into an aggregate 37,994 shares of Issuer common stock.
F2: Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock was exchanged on August 17, 2017 for the right to receive 1.123 newly issued shares of Sabra's common stock (the "Merger Consideration"), subject to certain adjustments as set forth in the Merger Agreement. The closing price of shares of Sabra's common stock on August 16, 2017 was $21.72 per share.
F3: Fully vested.
F4: These options were granted on January 27, 2016 and were scheduled to vest in three equal annual installments beginning on the date of the grant.
F5: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2021 Filed Dec 2, 2021 21:44 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 789 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-21-000100 · wf-form4_163848145741480.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,820 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 3,916 unvested stock units and 30,968 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:22 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 628 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-21-000074 · wf-form4_163061412486873.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,031 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 5,465 unvested stock units and 28,630 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 18:52 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 6,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-21-000047 · wf-form4_162395593140579.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,403 F1 · shares: Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 16, 2021 and ending on the earlier of June 15, 2022 or the day before the date of the next annual stockholders' meeting. F2 · balance_after: Includes 6,438 unvested stock units and 27,029 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 18:16 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-21-000027 · wf-form4_162265776396968.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,965 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 633 unvested stock units and 26,396 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 00:58 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 454 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-21-000045 · wf-form4_161473310848562.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,508 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 2,487 unvested stock units and 24,085 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| November 30, 2020 Filed Dec 3, 2020 00:39 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 467 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-20-000131 · wf-form4_160695593655713.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,054 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 4,276 unvested stock units and 21,842 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 22:47 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 508 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-20-000111 · wf-form4_159908685647962.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,587 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 5,999 unvested stock units and 19,652 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 09, 2020 Filed Jun 12, 2020 01:42 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 7,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-20-000089 · wf-form4_159192616064742.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,079 F1 · shares: Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 9, 2020 and ending on the earlier of June 8, 2020 or the day before the date of the next annual stockholders' meeting. F2 · balance_after: Includes 7,055 unvested stock units and 18,088 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 20:35 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 394 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-20-000073 · wf-form4_159113011773329.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,024 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 532 unvested stock units and 17,556 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| February 28, 2020 Filed Mar 4, 2020 00:31 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 399 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-20-000043 · wf-form4_158328186096404.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,630 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 2,085 unvested stock units and 15,609 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. F3 · balance_after: Includes 120,000 shares that were previously held in a grantor retained annuity trust of which the reporting person was the sole trustee and sole beneficiary and that were transferred to direct ownership on December 13, 2019. Read SEC document |
| November 29, 2019 Filed Dec 4, 2019 00:29 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 342 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-19-000149 · wf-form4_157541934132622.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,231 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 3,568 unvested stock units and 13,727 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 30, 2019 Filed Sep 4, 2019 22:09 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 346 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-19-000119 · wf-form4_156763496056049.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,889 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 4,998 unvested stock units and 11,955 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 20:43 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | SaleCommon Stock | 58,000 | $21.47 | $1,245,509.40 |
DisclosureSEC source: 0001510192-19-000099 · wf-form4_156693857007446.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,543 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.39 to $21.625, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 4,897 unvested stock units and 11,710 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 18:21 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 5,876 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-19-000080 · wf-form4_156148687086648.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,543 F1 · shares: Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 21, 2019 and ending on the earlier of June 20, 2020 or the day before the date of the next annual stockholders' meeting. F2 · balance_after: Includes 5,876 unvested stock units and 10,731 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 23:21 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 244 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-19-000072 · wf-form4_155969045341534.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,667 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 446 unvested stock units and 10,285 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. F3 · balance_after: On June 4, 2019, the reporting person contributed 120,000 shares of the Issuer's common stock to a grantor retained annuity trust of which the reporting person is the sole trustee and sole beneficiary. Read SEC document |
| February 28, 2019 Filed Mar 5, 2019 02:51 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-19-000035 · wf-form4_155175427561056.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,423 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 1,749 unvested stock units and 8,738 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. F3 · balance_after: Includes 120,000 shares that were previously held in a grantor retained annuity trust of which the reporting person was the sole trustee and sole beneficiary and that were transferred to direct ownership on February 13, 2019. Read SEC document |
| November 30, 2018 Filed Dec 4, 2018 18:22 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-18-000132 · wf-form4_154394776244974.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,169 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 2,990 unvested stock units and 7,243 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 31, 2018 Filed Sep 5, 2018 22:24 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-18-000104 · wf-form4_153618623106576.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,935 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 4,176 unvested stock units and 5,823 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 21, 2018 Filed Jun 21, 2018 23:43 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 4,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-18-000081 · wf-form4_152962459645408.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,749 F1 · shares: Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 21, 2018 and ending on the earlier of June 20, 2019 or the day before the date of the next annual stockholders' meeting. F2 · balance_after: Includes 4,918 unvested stock units and 4,895 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 01:59 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 104 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-18-000065 · wf-form4_152816395579374.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,831 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 489 unvested stock units and 4,406 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. F3 · balance_after: On April 5, 2018, the reporting person contributed 120,000 shares of the Issuer's common stock to a grantor retained annuity trust of which the reporting person is the sole trustee and sole beneficiary. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 16:41 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-18-000032 · wf-form4_152000889310777.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,727 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 1,915 unvested stock units and 2,876 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| November 30, 2017 Filed Dec 4, 2017 20:35 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 122 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-17-000125 · wf-form4_151241970238557.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,602 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 3,266 unvested stock units and 1,400 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 17:33 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | Disposition to issuerStock Option (Right to Buy) · Derivative | 321,456 | Not disclosed Strike: $29.94 | Not disclosed |
DisclosureSEC source: 0001104659-17-052709 · a4.xml · derivative · entry 7 Lewis Raymond J · CIK 0001215187 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 321,456 shares Expires 2026-01-27 F5 · price: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F4 · derivative.exercise_date: These options were granted on January 27, 2016 and were scheduled to vest in three equal annual installments beginning on the date of the grant. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 17:33 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | Disposition to issuerStock Option (Right to Buy) · Derivative | 198,525 | Not disclosed Strike: $38.28 | Not disclosed |
DisclosureSEC source: 0001104659-17-052709 · a4.xml · derivative · entry 6 Lewis Raymond J · CIK 0001215187 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 198,525 shares Expires 2025-01-21 F5 · price: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F3 · derivative.exercise_date: Fully vested. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 17:33 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | Disposition to issuerStock Option (Right to Buy) · Derivative | 269,431 | Not disclosed Strike: $30.10 | Not disclosed |
DisclosureSEC source: 0001104659-17-052709 · a4.xml · derivative · entry 5 Lewis Raymond J · CIK 0001215187 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 269,431 shares Expires 2024-01-29 F5 · price: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F3 · derivative.exercise_date: Fully vested. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 17:33 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | Disposition to issuerStock Option (Right to Buy) · Derivative | 161,668 | Not disclosed Strike: $32.22 | Not disclosed |
DisclosureSEC source: 0001104659-17-052709 · a4.xml · derivative · entry 4 Lewis Raymond J · CIK 0001215187 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 161,668 shares Expires 2023-01-23 F5 · price: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F3 · derivative.exercise_date: Fully vested. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 17:33 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | Disposition to issuerStock Option (Right to Buy) · Derivative | 139,802 | Not disclosed Strike: $27.22 | Not disclosed |
DisclosureSEC source: 0001104659-17-052709 · a4.xml · derivative · entry 3 Lewis Raymond J · CIK 0001215187 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 139,802 shares Expires 2022-01-18 F5 · price: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. F3 · derivative.exercise_date: Fully vested. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, each stock option, whether vested or unvested, that was outstanding and unexercised immediately prior to the effective time of the Merger vested in full (if not already vested), was assumed by Sabra and was converted into a stock option award to purchase a number of shares of Sabra common stock, at an exercise price per share of Sabra common stock under such option, based on the exchange ratio provided in the Merger Agreement, and will remain exercisable in accordance with the terms and conditions applicable to the original stock option. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 17:33 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | Disposition to issuerCommon Stock | 282,862 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-17-052709 · a4.xml · nonDerivative · entry 2 Lewis Raymond J · CIK 0001215187 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · shares: Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock was exchanged on August 17, 2017 for the right to receive 1.123 newly issued shares of Sabra's common stock (the "Merger Consideration"), subject to certain adjustments as set forth in the Merger Agreement. The closing price of shares of Sabra's common stock on August 16, 2017 was $21.72 per share. F2 · price: Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock was exchanged on August 17, 2017 for the right to receive 1.123 newly issued shares of Sabra's common stock (the "Merger Consideration"), subject to certain adjustments as set forth in the Merger Agreement. The closing price of shares of Sabra's common stock on August 16, 2017 was $21.72 per share. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 17:33 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | GrantCommon Stock | 37,994 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-17-052709 · a4.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,862 F1 · shares: Pursuant to an Agreement and Plan of Merger, dated May 7, 2017 (the "Merger Agreement"), by and among Sabra Health Care REIT, Inc., a Maryland corporation ("Sabra"), Sabra Health Care Limited Partnership, a Delaware limited partnership, PR Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Sabra ("Merger Sub"), Care Capital Properties, Inc., a Delaware corporation (the "Issuer"), and Care Capital Properties, LP, a Delaware limited partnership, the outstanding performance-based restricted stock units held by the Reporting Person immediately prior to the effective time of the merger (the "Merger") of Issuer with and into Merger Sub vested in full and were converted into an aggregate 37,994 shares of Issuer common stock. F1 · price: Pursuant to an Agreement and Plan of Merger, dated May 7, 2017 (the "Merger Agreement"), by and among Sabra Health Care REIT, Inc., a Maryland corporation ("Sabra"), Sabra Health Care Limited Partnership, a Delaware limited partnership, PR Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Sabra ("Merger Sub"), Care Capital Properties, Inc., a Delaware corporation (the "Issuer"), and Care Capital Properties, LP, a Delaware limited partnership, the outstanding performance-based restricted stock units held by the Reporting Person immediately prior to the effective time of the merger (the "Merger") of Issuer with and into Merger Sub vested in full and were converted into an aggregate 37,994 shares of Issuer common stock. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 23:54 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantStock Option (Right to Buy) · Derivative | 360,995 | Not disclosed Strike: $26.67 | Not disclosed |
DisclosureSEC source: 0001510192-17-000088 · wf-form4_150335967141504.xml · derivative · entry 9 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,995 Underlying: Common Stock · 360,995 shares Expires 2026-01-27 F10 · price: Received in the Merger in exchange for an employee stock option to acquire 321,456 shares of CCP common stock for $29.94 per share. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 23:54 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantStock Option (Right to Buy) · Derivative | 222,942 | Not disclosed Strike: $34.09 | Not disclosed |
DisclosureSEC source: 0001510192-17-000088 · wf-form4_150335967141504.xml · derivative · entry 8 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,942 Underlying: Common Stock · 222,942 shares Expires 2025-01-21 F9 · price: Received in the Merger in exchange for an employee stock option to acquire 198,525 shares of CCP common stock for $38.28 per share. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 23:54 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantStock Option (Right to Buy) · Derivative | 302,570 | Not disclosed Strike: $26.81 | Not disclosed |
DisclosureSEC source: 0001510192-17-000088 · wf-form4_150335967141504.xml · derivative · entry 7 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,570 Underlying: Common Stock · 302,570 shares Expires 2024-01-29 F8 · price: Received in the Merger in exchange for an employee stock option to acquire 269,431 shares of CCP common stock for $30.10 per share. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 23:54 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantStock Option (Right to Buy) · Derivative | 181,553 | Not disclosed Strike: $28.70 | Not disclosed |
DisclosureSEC source: 0001510192-17-000088 · wf-form4_150335967141504.xml · derivative · entry 6 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,553 Underlying: Common Stock · 181,553 shares Expires 2023-01-23 F7 · price: Received in the Merger in exchange for an employee stock option to acquire 161,668 shares of CCP common stock for $32.22 per share. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 23:54 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantStock Option (Right to Buy) · Derivative | 156,997 | Not disclosed Strike: $24.24 | Not disclosed |
DisclosureSEC source: 0001510192-17-000088 · wf-form4_150335967141504.xml · derivative · entry 5 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,997 Underlying: Common Stock · 156,997 shares Expires 2022-01-18 F6 · price: Received in the Merger in exchange for an employee stock option to acquire 139,802 shares of CCP common stock for $27.22 per share. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 23:54 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 4,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-17-000088 · wf-form4_150335967141504.xml · nonDerivative · entry 4 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,480 F4 · shares: Grant of restricted stock units under Sabra's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning September 19, 2017 and ending on the earlier of June 19, 2018 or the day before the date of the next annual stockholders' meeting. F5 · balance_after: Includes 4,544 unvested stock units. Each stock unit represents the right to receive one share of Sabra's common stock. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 23:54 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | Tax withholdingCommon Stock | 75,717 | $21.72 | $1,644,573.24 |
DisclosureSEC source: 0001510192-17-000088 · wf-form4_150335967141504.xml · nonDerivative · entry 3 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,936 F3 · shares: Represents shares withheld by Sabra in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the vesting of the restricted stock and RSUs, each as reported herein. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 23:54 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 42,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001510192-17-000088 · wf-form4_150335967141504.xml · nonDerivative · entry 2 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,653 F2 · price: Received in exchange for 37,994 shares of CCP common stock subject to a restricted stock unit ("RSU") award, in connection with the Merger. In accordance with the terms of the Merger, each CCP RSU award vested in full, was assumed by Sabra, was converted into a stock unit award with respect to Sabra common stock (giving effect to the 1.123 exchange ratio and rounding to the nearest whole share), and became payable in connection with the Merger. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 23:54 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 274,986 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001510192-17-000088 · wf-form4_150335967141504.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,986 F1 · price: Received in exchange for 139,100 shares of Care Capital Properties, Inc. ("CCP") common stock and 105,768 shares of CCP restricted stock, in connection with the acquisition of CCP by Sabra Health Care REIT, Inc. ("Sabra") (the "Merger"). In accordance with the terms of the Merger, (a) each share of CCP common stock was converted into the right to receive 1.123 shares of Sabra common stock, with cash paid in lieu of fractional shares, and (b) each share of CCP restricted stock vested in full and was converted into the right to receive 1.123 shares of Sabra common stock, with cash paid in lieu of fractional shares. At the effective time of the Merger, the last traded price of CCP's common stock was $24.21 per share, and the last traded price of Sabra's common stock was $21.72 per share. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 16:37 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | Tax withholdingCommon Stock | 8,127 | $25.46 | $206,913.42 |
DisclosureSEC source: 0001639947-17-000021 · wf-form4_148676263886381.xml · nonDerivative · entry 2 Lewis Raymond J · CIK 0001215187 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,868 F2 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on February 8, 2017 under the Plan. F3 · balance_after: As of February 8, 2017, Reporting Person also owns options to purchase an aggregate of 1,090,882 shares of Issuer's common stock. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 16:37 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | GrantCommon Stock | 53,355 | $0.00 | $0.00 |
DisclosureSEC source: 0001639947-17-000021 · wf-form4_148676263886381.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,995 F1 · shares: Restricted stock granted by Issuer pursuant to the Care Capital Properties, Inc. 2015 Incentive Plan (the "Plan"). This restricted stock vests in three equal annual installments beginning on the date of the grant. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 16:39 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | Tax withholdingCommon Stock | 6,609 | $24.51 | $161,986.59 |
DisclosureSEC source: 0001639947-17-000016 · wf-form4_148589876148342.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,640 F1 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock granted on January 27, 2016 under the Care Capital Properties, Inc. 2015 Incentive Plan. F2 · balance_after: As of January 27, 2017, Reporting Person also owns options to purchase an aggregate of 1,090,882 shares of Issuer's common stock. Read SEC document |
| January 21, 2017 Filed Jan 24, 2017 16:58 UTC | Care Capital Properties, Inc. CCP · Entity 173690 | Tax withholdingCommon Stock | 3,647 | $25.04 | $91,320.88 |
DisclosureSEC source: 0001639947-17-000008 · wf-form4_148529508569363.xml · nonDerivative · entry 1 Lewis Raymond J · CIK 0001215187 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,249 F1 · shares: Represents shares withheld to pay the taxes on the vesting of restricted stock originally granted by Ventas, Inc. ("Ventas") on January 21, 2015 under the Ventas 2012 Incentive Plan that was converted into Issuer restricted stock in connection with the spin off of the Issuer from Ventas on August 17, 2015. F2 · balance_after: As of January 21, 2017, Reporting Person also owns options to purchase an aggregate of 1,090,882 shares of Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.